{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:19:04Z","timestamp":1649143144038},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ymgme.2006.06.008","type":"journal-article","created":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T07:13:23Z","timestamp":1155885203000},"page":"112","source":"Crossref","is-referenced-by-count":0,"title":["Doxycycline and rifampin could be useful therapeutic agents for Gaucher disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Joseph Martin","family":"Alisky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2006.06.008_bib1","first-page":"363","article-title":"Gaucher disease and brucella: just a mere coincidence","volume":"14","author":"Turfaner Erturk","year":"2003","journal-title":"Genet. Couns."},{"key":"10.1016\/j.ymgme.2006.06.008_bib2","first-page":"3","article-title":"Gaucher disease: from fundamental research to effective therapeutic interventions","volume":"61","author":"deFost","year":"2003","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.ymgme.2006.06.008_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/adc.75.3.218","article-title":"Effective treatment of painful bone crises in type I gaucher\u2019s disease with high dose prednisolone","volume":"75","author":"Cohen","year":"1996","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.ymgme.2006.06.008_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0192-0561(84)90034-1","article-title":"In vitro inhibition of natural killer cell activity by doxycycline","volume":"6","author":"Goh","year":"1984","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ymgme.2006.06.008_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2006.06.008_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nm0198-092","article-title":"The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor","volume":"4","author":"Calleja","year":"1998","journal-title":"Nat. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920600223X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920600223X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T01:23:34Z","timestamp":1547429014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671920600223X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S109671920600223X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2006.06.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}